VolitionRx Limited (VNRX) Operating income 2016–2025
VolitionRx Limited (VNRX) annual operating income history from SEC filings — each fiscal year as reported.
-$21.7MFY2025 · since FY2016: -$12.4M → -$21.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$21.7M | +19.6% |
| FY2024 | -$27.0M | +24.9% |
| FY2023 | -$36.0M | -13.2% |
| FY2022 | -$31.8M | -12.2% |
| FY2021 | -$28.3M | -33.3% |
| FY2020 | -$21.2M | -32.4% |
| FY2019 | -$16.0M | +10.4% |
| FY2018 | -$17.9M | -21.8% |
| FY2017 | -$14.7M | -18.2% |
| FY2016 | -$12.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VNRX financial trends
VNRX RevenueVNRX Net incomeVNRX Net marginVNRX Gross profitVNRX Gross marginVNRX Operating marginVNRX Operating cash flowVNRX Free cash flowVNRX Capital expendituresVNRX Return on equityVNRX Stock buybacksVNRX Dividends paidVNRX Total assetsVNRX Total liabilitiesVNRX Shareholders’ equityVNRX overview →